Please use a PC Browser to access Register-Tadawul
Is Zions (ZION) Using Its New Senior Notes To Quietly Reposition Interest Rate Risk?
Zions Bancorporation NA ZION | 62.50 | +1.66% |
- Zions Bancorporation, N.A. recently priced and settled a US$500,000,000 fixed‑to‑floating rate senior notes offering due February 9, 2029, with a 4.483% fixed coupon to February 2028 and a subsequent Compounded SOFR plus 1.055% floating rate.
- The bank plans to use the proceeds to pay down short‑term borrowings while a receive‑fixed hedge converts the new debt cost to floating, reshaping its interest rate risk profile.
- We’ll now examine how this US$500,000,000 senior notes issuance and refinancing of short‑term borrowings may influence Zions’ investment narrative.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
Zions Bancorporation National Association Investment Narrative Recap
To own Zions Bancorporation, N.A., you need to be comfortable with a regional bank focused on the Western U.S., where credit quality, deposit mix, and commercial real estate exposure remain central. The new US$500,000,000 fixed to floating notes mainly tidy up funding and interest rate positioning, and do not materially change the near term catalysts around digital execution or the key risks from CRE and deposit competition.
The recent authorization of up to US$75,000,000 in share buybacks sits alongside this new debt issuance, giving a clearer picture of how Zions is balancing capital returns with balance sheet management. For investors watching earnings power and capital resilience, the combination of steady dividends, measured repurchases, and refinanced funding costs frames much of the short term narrative.
Yet, for all of this, Zions' concentrated exposure to Western commercial real estate remains something investors should be aware of...
Zions Bancorporation National Association's narrative projects $3.5 billion revenue and $818.0 million earnings by 2028.
Uncover how Zions Bancorporation National Association's forecasts yield a $66.57 fair value, a 9% upside to its current price.
Exploring Other Perspectives
Three fair value estimates from the Simply Wall St Community span from about US$66.57 to an extreme outlier above US$44,000 per share, showing how far opinions can stretch. Against that backdrop, the concentration risk in Western commercial real estate and regional economies gives you a concrete issue to weigh as you compare these very different viewpoints.
Explore 3 other fair value estimates on Zions Bancorporation National Association - why the stock might be a potential multi-bagger!
Build Your Own Zions Bancorporation National Association Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Zions Bancorporation National Association research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Zions Bancorporation National Association research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Zions Bancorporation National Association's overall financial health at a glance.
Curious About Other Options?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Find 54 companies with promising cash flow potential yet trading below their fair value.
- Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.


